US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Synbio International Inc.

0.0017

0.0000

Volume:10.10K

Turnover:15.17

Market Cap:581.40K

PE:-1.39

High:0.0017

Open:0.0015

Low:0.0015

Close:0.0017

52wk High:0.0060

52wk Low:0.0008

Shares:342.00M

Float Shares:276.26M

Volume Ratio:0.02

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0012

EPS(LYR):-0.0012

ROE:--

ROA:--

PB:-1.31

PE(LYR):-1.39

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Synbio International Signs Agreement for Clinical Trial of AI-Based Mental Health Screening Tool

Synbio International Inc. Expands Its Board of Directors and Strengthens Its Clinical Leadership With the Appointment of DR. Nick Vatakis

THOMSON REUTERS

BRIEF-Synbio International Inc. Strengthens Strategic Alliance With FacialDx Through Share Purchase And Warrant Agreements

Synbio International Inc. Strengthens Strategic Alliance With Facialdx Inc. Through Share Purchase and Warrant Agreements

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SYIN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SYIN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYIN\",,,,,undefined,":{"symbol":"SYIN","market":"US","secType":"STK","nameCN":"Synbio International Inc. ","latestPrice":0.0017,"timestamp":1779808283716,"preClose":0.0017,"halted":0,"volume":10100,"delay":15,"changeRate":0,"floatShares":276256511,"shares":342000000,"eps":-0.00122,"marketStatus":"Trading","change":0,"latestTime":"05-26 11:11:23 EDT Delay","open":0.0015,"high":0.0017,"low":0.0015,"amount":15.17,"amplitude":0.117647,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.00122,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779825600000},"marketStatusCode":2,"adr":0,"exchange":"PINK","adjPreClose":0.0017,"volumeRatio":0.022421},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYIN\",,,,,undefined,":{"symbol":"SYIN","floatShares":276256511,"roa":"--","roe":"--","lyrEps":-0.00122,"volumeRatio":0.022421,"shares":342000000,"dividePrice":0,"high":0.0017,"amplitude":0.117647,"preClose":0.0017,"low":0.0015,"week52Low":0.0008,"pbRate":"-1.31","week52High":0.006,"institutionHeld":0,"latestPrice":0.0017,"eps":-0.00122,"divideRate":0,"volume":10100,"delay":15,"ttmEps":-0.00122,"open":0.0015,"prevYearClose":0.0024,"prevWeekClose":0.0017,"prevMonthClose":0.0013,"prevQuarterClose":0.0013,"fiveDayClose":0.0015,"twentyDayClose":0.0016,"sixtyDayClose":0.0025},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SYIN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SYIN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SYIN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SYIN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603600986","title":"Synbio International Signs Agreement for Clinical Trial of AI-Based Mental Health Screening Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2603600986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603600986?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:03","pubTimestamp":1768482183,"startTime":"0","endTime":"0","summary":"Synbio International Inc. announced that it has signed a Master Services Agreement with CRO Services Pty Ltd, a subsidiary of Resonance Health Ltd. Under the agreement, CRO Services will conduct a proof-of-concept clinical trial in Australia to evaluate the efficacy of FacialDx Incorporated’s NIMS  technology. The trial will assess the performance of the AI-powered facial analysis screening software for mental health disorders, such as Post-Traumatic Stress Disorder and Major Depressive Disorder, in real-world clinical conditions. The data from the study is intended to support future regulatory submissions and inform Synbio’s commercialization strategy in healthcare and corporate markets. The trial is expected to begin in early 2026, pending finalization of related agreements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDLc44Zj8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHT.AU","LU1923622291.USD","LU2028103732.USD","LU2089283258.USD","LU1481600234.SGD","LU1487256676.USD","BK5061","LU1196032939.SGD","LU2125909916.SGD","LU2271345857.HKD","LU2111349929.HKD","LU0158827781.USD","LU0158827948.USD","SYIN","BK7007","LU2125909759.SGD","RTO.UK","LU2023251221.USD","LU1273509221.SGD","LU2089284900.SGD","LU1481599808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577136277","title":"Synbio International Inc. Expands Its Board of Directors and Strengthens Its Clinical Leadership With the Appointment of DR. Nick Vatakis","url":"https://stock-news.laohu8.com/highlight/detail?id=2577136277","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577136277?lang=en_us&edition=fundamental","pubTime":"2025-10-22 21:00","pubTimestamp":1761138004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nTUA53BK6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SYIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2573992645","title":"BRIEF-Synbio International Inc. Strengthens Strategic Alliance With FacialDx Through Share Purchase And Warrant Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2573992645","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573992645?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:19","pubTimestamp":1759929544,"startTime":"0","endTime":"0","summary":"BRIEF-Synbio International Inc. Strengthens Strategic Alliance With FacialDx Through Share Purchase And Warrant AgreementsOct 8 (Reuters) - Synbio International Inc SYIN.PK:SYNBIO INTERNATIONAL INC. S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUAG5MWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2573892509","title":"Synbio International Inc. Strengthens Strategic Alliance With Facialdx Inc. Through Share Purchase and Warrant Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2573892509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573892509?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:00","pubTimestamp":1759928403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUAG5MWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SYIN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SYIN\",params:#limit:6,delay:false,,,undefined,":[]}}